Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

281 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disease burden and patient characteristics associated with systemic therapy utilization among adults with atopic dermatitis: data from CorEvitas Atopic Dermatitis Registry.
Silverberg JI, Gold LS, Desai S, Golant A, DiRuggiero D, Fenske DC, Li A, Dawson Z, Muñoz Maldonado Y, Ho K, Callahan K, Simpson EL. Silverberg JI, et al. J Dermatolog Treat. 2024 Dec;35(1):2396382. doi: 10.1080/09546634.2024.2396382. Epub 2024 Sep 25. J Dermatolog Treat. 2024. PMID: 39322226 Free article.
A call to action: The need to update population descriptors in dermatology research studies with the use of an inclusive skin classification system.
Harvey VM, Brown SG 3rd, Burgess CM, Byrd AS, Cobb CBC, Desai SR, Heath CR, Jaleel T, McMichael AJ, Miller-Monthrope Y, Sundaram H, Takeshita J, Taylor SC, Weiss JS, Yoo J, Callender VD. Harvey VM, et al. Among authors: desai sr. J Am Acad Dermatol. 2025 Jan 20:S0190-9622(25)00106-9. doi: 10.1016/j.jaad.2025.01.029. Online ahead of print. J Am Acad Dermatol. 2025. PMID: 39842722 No abstract available.
Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation.
Hamzavi IH, Ganesan AK, Mahmoud BH, Weiss E, Ahmed AM, Robinson D, Goldman MP, Munavalli G, Kahn SA, Huang V, Waibel J, Desai A, Elbuluk N, Desai S, Pandya AG. Hamzavi IH, et al. J Am Acad Dermatol. 2024 Dec;91(6):1104-1112. doi: 10.1016/j.jaad.2024.08.027. Epub 2024 Sep 7. J Am Acad Dermatol. 2024. PMID: 39182674 Free article. Clinical Trial.
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients.
Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, Huang V, Desai SR, Walsh S, Silverberg JI, Paller AS, Rodrigues M, Weingarten M, Narla S, Gardner J, Siegel M, Ibad S, Silverberg NB. Renert-Yuval Y, et al. Among authors: desai sr. JAMA Dermatol. 2024 Apr 1;160(4):453-461. doi: 10.1001/jamadermatol.2024.0021. JAMA Dermatol. 2024. PMID: 38477910 Review.
Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation.
Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, Desai SR, York JP, Chavda R, Dhawan S, Moore AY, Stein-Gold L. Alexis A, et al. Among authors: desai sr. Int J Dermatol. 2024 Jun;63(6):806-815. doi: 10.1111/ijd.17189. Epub 2024 Apr 29. Int J Dermatol. 2024. PMID: 38685118 Clinical Trial.
281 results